Class of 2026
For pioneering translational and clinical cancer research that has led to the development of numerous next-generation targeted therapies, as well as the clinical evaluation of novel mechanistic combination strategies that have guided the field of precision oncology and transformed clinical practice.
*Full-length biography in development
[Institutional affiliations listed for Fellows reflect those held at the time of their induction into the AACR Academy.]